COVID-19 crisis brings CRISPR-Cas13 research into the spotlight
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
It makes sense that CRISPR-Cas13 would enter the limelight during the COVID-19 crisis, given that the SARS-CoV-2 is an RNA virus, and this Cas enzyme targets RNA.
With diagnostics one of the most critical components of this outbreak, the CRISPR-based diagnostic system could offer a new dimension to the suite of tools that are too-slowly coming into play, at least in the U.S.
In the short term, CRISPR-based diagnostics can offer shorter